- Noteworthy events in healthcare next week:
- Tuesday (1/23): Johnson & Johnson (NYSE:JNJ) Q4 earnings. EMA's Committee for Medicinal Products for Human Use (CHMP) oral hearing on Puma Biotech's (NYSE:PBYI) neratinib marketing application. The Medicines Company (NASDAQ:MDCO) Investor Day.
- Wednesday (1/24): Abbott (NYSE:ABT) Q4 earnings. FDA Ad Com meeting on modified-risk tobacco products (NYSE:MO)(two days). FDA action date for Synergy Pharma's (NASDAQ:SGYP) Trulance for IBS-C.
- Thursday (1/25): Quarterly earnings for Celgene (NASDAQ:CELG), Biogen (NASDAQ:BIIB) and Dr. Reddy's Labs (NYSE:RDY).
- Friday (1/26): Quarterly earnings for Hill-Rom Holdings (NYSE:HRC) and AbbVie (NYSE:ABBV). FDA action date for Aradigm's (NASDAQ:ARDM) Linhaliq for non-CF bronchiectasis. FDA action date for Roche's (OTCQX:RHHBY) Perjeta for HER2+ breast cancer (actual action date is Sunday, 1/28).
- Now read: Juno Therapeutics: What The Celgene Potential Acquisition Foretells
Original article